Isofol Medical AB (ISOFOL) NPV

Sell:2.95 SEKBuy:2.97 SEK0.06 SEK (1.84%)

Prices delayed by at least 15 minutes
Sell:2.95 SEK
Buy:2.97 SEK
Change:0.06 SEK (1.84%)
Prices delayed by at least 15 minutes
Sell:2.95 SEK
Buy:2.97 SEK
Change:0.06 SEK (1.84%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
23 September 2024
Margareta HagmanCFO
Buy
Regular purchase transaction
40,0002.56 SEK102,400.00 SEK40,000
13 September 2024
Magnus HurstCFO
Sell
Regular sell transaction (market)
35,5002.57 SEK91,235.00 SEK0
21 August 2024
Petter Segelman LindqvistCEO
Buy
Regular purchase transaction
7,7772.69 SEK20,955.90 SEK63,331
12 July 2024
Petter Segelman LindqvistCEO
Buy
Regular purchase transaction
7,7772.47 SEK19,170.31 SEK55,554
5 July 2024
Petter Segelman LindqvistCEO
Buy
Regular purchase transaction
7,7770.94 SEK7,287.05 SEK47,777
26 March 2024
Petter Segelman LindqvistCEO
Buy
Regular purchase transaction
6,3480.80 SEK5,091.10 SEK40,000
11 January 2024
Magnus HurstCFO
Buy
Regular purchase transaction
35,0000.69 SEK24,150.00 SEK35,500

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
23 September 2024
Margareta HagmanCFO
Buy
Regular purchase transaction
40,0002.56 SEK102,400.00 SEK40,000
13 September 2024
Magnus HurstCFO
Sell
Regular sell transaction (market)
35,5002.57 SEK91,235.00 SEK0
11 January 2024
Magnus HurstCFO
Buy
Regular purchase transaction
35,0000.69 SEK24,150.00 SEK35,500
21 August 2024
Petter Segelman LindqvistCEO
Buy
Regular purchase transaction
7,7772.69 SEK20,955.90 SEK63,331
12 July 2024
Petter Segelman LindqvistCEO
Buy
Regular purchase transaction
7,7772.47 SEK19,170.31 SEK55,554

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.